Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Rackspace Technology
RXT
$1.21B
| $979K | ﹤0.01% |
579,370
-16,490
| -3% | -$39.3K |
|
2852
Southern California Bancorp
BCAL
$687M
| $978K | ﹤0.01% |
68,274
+13
| +0% | +$202 |
|
2853
Nektar Therapeutics
NKTR
$2.47B
| $975K | ﹤0.01% |
95,630
-2,114
| -2% | -$27.6K |
|
2854
Heritage Insurance Holdings
HRTG
$915M
| $964K | ﹤0.01% |
66,874
| – | – |
|
2855
Hallador Energy
HNRG
$696M
| $962K | ﹤0.01% |
78,300
-5,000
| -6% | -$56.2K |
|
2856
Omega Flex
OFLX
$307M
| $958K | ﹤0.01% |
27,532
-599
| -2% | -$23.2K |
|
2857
908 Devices
MASS
$345M
| $951K | ﹤0.01% |
212,230
+10,462
| +5% | +$31K |
|
2858
Matrix Service
MTRX
$325M
| $944K | ﹤0.01% |
75,939
+96
| +0.1% | +$1.28K |
|
2859
EVgo
EVGO
$216M
| $941K | ﹤0.01% |
353,653
+54,859
| +18% | +$170K |
|
2860
Expensify
EXFY
$195M
| $939K | ﹤0.01% |
308,738
-8,238
| -3% | -$28.6K |
|
2861
Genmab
GMAB
$18B
| $937K | ﹤0.01% |
47,874
-13,303
| -22% | -$279K |
|
|
ONL
2862
Orion Office REIT
ONL
$154M
| $932K | ﹤0.01% |
435,427
-173,451
| -28% | -$606K |
|
2863
Orchestra BioMed
OBIO
$253M
| $929K | ﹤0.01% |
216,985
-1,670
| -0.8% | -$8.3K |
|
2864
Home Bancorp
HBCP
$567M
| $928K | ﹤0.01% |
20,711
| – | – |
|
2865
Ooma
OOMA
$590M
| $928K | ﹤0.01% |
70,866
-9
| -0% | -$128 |
|
2866
Perspective Therapeutics
CATX
$335M
| $925K | ﹤0.01% |
434,085
+27,119
| +7% | +$81.4K |
|
2867
Luxfer Holdings
LXFR
$458M
| $920K | ﹤0.01% |
77,575
| – | – |
|
2868
Intrepid Potash
IPI
$453M
| $919K | ﹤0.01% |
31,254
+1,212
| +4% | +$32K |
|
|
ZBIO
2869
Zenas BioPharma
ZBIO
$2.01B
| $918K | ﹤0.01% |
116,140
-2,520
| -2% | -$19.7K |
|
|
GNTY
2870
DELISTED
Guaranty Bancshares
GNTY
| $915K | ﹤0.01% |
22,848
+9
| +0% | +$355 |
|
2871
4D Molecular Therapeutics
FDMT
$537M
| $913K | ﹤0.01% |
282,781
-25,828
| -8% | -$122K |
|
|
RAPP
2872
Rapport Therapeutics
RAPP
$2.03B
| $912K | ﹤0.01% |
90,968
+17,459
| +24% | +$227K |
|
2873
Spok Holdings
SPOK
$235M
| $909K | ﹤0.01% |
55,314
+1,966
| +4% | +$32K |
|
2874
Pagaya Technologies
PGY
$1.82B
| $907K | ﹤0.01% |
86,512
+13
| +0% | +$144 |
|
2875
West Bancorporation
WTBA
$482M
| $900K | ﹤0.01% |
45,147
+20
| +0% | +$427 |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.